Results 291 to 300 of about 116,300 (353)
Activated partial thromboplastin time (APTT), partial thromboplastin time (PTT)
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Activated Partial Thromboplastin Time
Methods in molecular biology, 2013Activated partial thromboplastin time (APTT) is a commonly used coagulation assay that is easy to perform, is affordable, and is therefore performed in most coagulation laboratories, both clinical and research, worldwide. The APTT is based on the principle that in citrated plasma, the addition of a platelet substitute, factor XII activator, and CaCl2 ...
V. Ignjatovic
openaire +3 more sources
Biologicals, 2010
The Prothrombin Time (PT) test is used for monitoring of treatment with Vitamin K-antagonists (VKA). The result of the PT test should be expressed as the International Normalized Ratio (INR). Calculation of INR is based on the availability of International Standards (IS) for thromboplastin and a calibration model. Calibration of a new PT test system is
A. M. van den Besselaar +2 more
openaire +4 more sources
The Prothrombin Time (PT) test is used for monitoring of treatment with Vitamin K-antagonists (VKA). The result of the PT test should be expressed as the International Normalized Ratio (INR). Calculation of INR is based on the availability of International Standards (IS) for thromboplastin and a calibration model. Calibration of a new PT test system is
A. M. van den Besselaar +2 more
openaire +4 more sources
Plasma Thromboplastin Antecedent
A.M.A. Archives of Internal Medicine, 1955Until recently, male persons with a severe hemorrhagic diathesis characterized by (1) a prolonged clotting time, (2) normal Quick plasma prothrombin time, but (3) a poor prothrombin consumption were unhesitatingly diagnosed as suffering from classic hemophilia.
B, RAMOT, B, ANGELOPOULOS, K, SINGER
openaire +2 more sources
Calibration of thromboplastins
Proceedings of the Royal Society of London. Series B: Biological Sciences, 1995Anticoagulant therapy with coumarin drugs requires tests on the patient's blood to determine the dose rate for the drug. The tests involve measuring the effect of a preparation of a certain reagent, thromboplastin, in accelerating the clotting of the patient's blood.
openaire +2 more sources
THROMBOPLASTIN REFERENCE PREPARATIONS
Scandinavian Journal of Haematology, 1980The need for standardization of methods for the control of anticoagulant therapy was apparent 25 years ago. With the development of the ratio method for comparing the sensitivity of different thromboplastin preparations it became possible to equate the value obtained with one preparation in terms of the value which would be obtained with any other ...
openaire +2 more sources
Thromboplastin Generation Test
JAMA: The Journal of the American Medical Association, 1967In the classical theory of blood coagulation, it was postulated that prothrombin was converted to thrombin through the action of calcium and thromboplastin. It is now established that circulating blood contains no active thromboplastin but that thromboplastin is generated during coagulation.
openaire +2 more sources
Thromboplastin generation by saliva
Oral Surgery, Oral Medicine, Oral Pathology, 1962Abstract In order to determine directly whether saliva has any specific thromboplastic activity or whether its effect in accelerating blood coagulation is nonspecific, we compared saliva with commercial tissue thromboplastins in the following modified hematologic tests: 1. 1.
H C, DOKU, R G, TAYLOR
openaire +2 more sources
1984
A few years ago, a field trial was carried out in which a large number of plasma samples (100 normals, 806 anticoagulated patients, as well as patients with deficiencies of the factors II, V, VII and X) were tested with a newly developed rabbit brain thromboplastin (Thromboplastin FS) and with Human Brain Thromboplastin prepared by Prof.
R. Spaethe, I. Shirley
openaire +1 more source
A few years ago, a field trial was carried out in which a large number of plasma samples (100 normals, 806 anticoagulated patients, as well as patients with deficiencies of the factors II, V, VII and X) were tested with a newly developed rabbit brain thromboplastin (Thromboplastin FS) and with Human Brain Thromboplastin prepared by Prof.
R. Spaethe, I. Shirley
openaire +1 more source

